250 words) 83 84 Invasive lobular carcinoma (ILC) is the second most common subtype of breast cancer following 85 invasive ductal carcinoma (IDC) and characterized by the loss of E-cadherin-mediated adherens 86 junctions. Despite displaying unique histological and clinical features, ILC still remains a 87 chronically understudied disease with limited knowledge on the available laboratory research 88 models. To this end, herein we report a comprehensive 2D and 3D phenotypic characterization of 89 four Estrogen Receptor-positive human ILC cell lines -MDA-MB-134, SUM44, MDA-MB-330 90 and BCK4. Compared to the IDC cell lines MCF7, T47D and MDA-MB-231, ultra-low 91 attachment culture conditions revealed a remarkable anchorage-independence ability that was 92 unique to the ILC cells, a feature not evident in soft agar gels. 3D Collagen I and Matrigel 93 culture indicated a generally loose morphology for the ILC cell lines, which exhibited differing 94 preferences for adhesion to ECM proteins in 2D. Furthermore, ILC cells had limited migration 95 and invasion ability in wound-scratch and transwell assays with the exception of haptotaxis to 96 Collagen I. Transcriptional comparison of the cell lines confirmed the decreased cell 97 proliferation and E-cadherin-mediated intercellular junctions in ILC, while uncovering the 98 induction of novel pathways related to cyclic nucleotide phosphodiesterase activity, ion 99 channels, drug metabolism and alternative cell adhesion molecules such as N-cadherin, some of 100 which were also differentially regulated in ILC versus IDC tumors. Altogether, these studies will 101 serve as an invaluable resource for the breast cancer research community and facilitate further 102 functional discoveries towards understanding ILC, identifying novel drug targets and ultimately 103 improving the outcome of patients with ILC.
Despite its distinctive histological and clinical features, ILC has remained a gravely understudied 139 subtype of breast cancer. The most characteristic feature of ILC is the lack of E-cadherin-140 mediated adherens junctions, thought to be largely responsible for its single-file growth pattern 141 (6). This hallmark E-cadherin loss, found in 95% of all ILC tumors versus in only 7% of IDCs, 142 occurs through truncating mutations and loss-of-heterozygosity (6) (7) (8) . Our knowledge of ILC as 143 a unique subtype of breast cancer is only recently emerging with comprehensive reports from big 144 consortia such as The Cancer Genome Atlas (TCGA) (7) and Rational Therapy for Breast Cancer 145 (RATHER) (9). Multi-omics profiling of human tumors has begun to reveal candidate disease 146 drivers such as HER2, HER3, FOXA1 and PIK3CA mutations, PTEN loss and ESR1 147 amplifications, events more frequently observed in ILC compared to IDC (7, 9, 10) . However, the 148 functional validation of these potential drivers is hindered by the availability of few ER-positive 149 human ILC cell lines for use in the laboratory and limited knowledge on their biological 150 phenotypes. Thus there is urgent need to develop additional cell line models, as well as 151 thoroughly characterizing the cellular behaviors of the existing ones. 152 153 Our laboratory has recently reported the first profiling of ER function and endocrine response in 154 ER-positive human ILC cell lines (11) . Here we go one step beyond and characterize their 155 growth and morphologies in 3D environments such as in ultra-low attachment (ULA) culture 156 (12), soft agar (13), and within/on top of ECM proteins (14, 15) , as well as their adhesion 157 properties in 2D (16). Using IDC cell lines for comparison, we probe their migration potential in 158 response to both soluble attractants in chemotaxis assays (17) and to substrate bound ECM 159 proteins in haptotaxis assays (18) . In addition, we report on their abilities to invade Collagen I 160 and Matrigel, as well as assessing their use of amoeboid invasion in non-cross-linked Collagen I 161 gels (19, 20) . Comparison of transcriptional profiling data of ER-positive human ILC and IDC 162 cell lines identified a number of clinically relevant genes and pathways that provide important 163 5 insights into the sub-type specific gene expression programs likely responsible for their divergent 164 biological phenotypes. Combined, our studies serve as invaluable resource for modeling ILC in 165 the laboratory and pave the way for a promising direction of research for ILC biology towards 166 new discoveries. (Sigma-Aldrich). SUM44 was maintained as described (11) in DMEM-F12 with 2% charcoal 214 stripped serum and supplements. Cell lines were routinely tested to be mycoplasma free, 215 authenticated by the University of Arizona Genetics Core by Short Tandem Repeat DNA 216 profiling and kept in continuous culture for <6 months. PIK3CA plasmids in pBABE (Addgene) 217 and PTEN shRNAs in pMLPE (a kind gift from Scott W. Lowe, Memorial Sloan Kettering 218 Cancer Center, NY) were packaged as previously described (21) and cells were selected with 219 1µg/ml puromycin (Life Technologies). shRNA sequences are provided in Supplementary Table   220 1. 221 222 Immunoassays and trichrome staining 223 224 Western blots were performed as previously described (22) using 5% milk powder for blocking 225 and developed using ECL (Sigma-Aldrich). For immunofluorescence, cells grown on coverslips 226 were fixed with 4% paraformaldehyde, permeabilized and blocked with 5% Normal Goat Serum. 227 Coverslips were incubated with antibodies, washed and mounted using DAPI-containing media 228 (Thermo Fisher Scientific). Slides were imaged using a Nikon A1 advanced confocal system. 229 Details of the antibodies used are included in Supplementary Table 1 . Masson's Trichrome 230 (Sigma-Aldrich) staining was performed on a tissue microarray using manufacturer's protocol 231 without the acetic acid step after the aniline blue.
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Anchorage-independence and stemness assays 234 235 For 2D and ULA growth assays, ILC (15,000/96-well; 300,000/6-well) and IDC (5,000/96-well; 236 100,000/6-well) cells were seeded in regular (Thermo Fisher Scientific) or ULA (Corning Life 237 Sciences) 96-well plates and assayed using CellTiter-Glo (Promega) on a Promega GloMax plate 238 reader. Soft agar assays with ILC (50,000/plate) and IDC (10,000/plate) cells were performed in 239 35-mm plates (Thermo Fisher Scientific) as previously described (13, 23) . For mammosphere 240 assays, ILC (60,000/well) and IDC (20,000/well) cells were seeded in 6-well ULA plates 241 (Corning Life Sciences) as previously described (24) in 1:1 DMEM/Ham's F-12 media with 20 242 ng/mL bFGF (BD Biosciences), 20 ng/mL EGF (BD Biosciences), B27 (Gibco), 2.5 mL 243 7 Penicillin/Streptomycin, and 4 µg/mL Heparin (Sigma-Aldrich). All images were taken on an 244 Olympus IX83 inverted microscope. For stem cell expression experiments, cells were stained 245 with the indicated antibodies and analyzed on an LSRII flow cytometer (BD Biosciences). 246 Gating was performed using the BD FACS Diva Software and isotype antibody stainings. Details 247 of the antibodies used are included in Supplementary Table 1. 248 249 3D ECM assays 250 251 ILC (15,000/well) and IDC (5,000) cells were embedded in rat-tail Collagen I (Corning Life 252 Sciences) at 4mg/ml in 24-well plates following manufacturer's recommendations. For Matrigel 253 (BD Biosciences) assays, ILC (5,000/well) and IDC (4,000/well) cells were seeded into single 254 wells of 8-well LabTek Chamber Slides (Thermo Fisher Scientific) as previously described (14). 255 Colonies were imaged on an Olympus IX83 inverted microscope. Hormone receptor and adherens junction status 326 327 In this study, we focused on four ER-positive human ILC cell lines -MDA-MB-134, SUM44, 328 MDA-MB-330 and BCK4 and utilized the IDC cell lines MCF7, T47D and MDA-MB-231 for 329 comparative studies. As seen in Fig. 1A Next we assessed the anchorage-independence ability of ILC cell lines by growing them in ULA 354 conditions, which forces them into a suspension culture (12). ILC cell lines exhibited a 355 dyscohesive, scattered morphology in 2D plates consistent with their lack of adherens junctions, 356 while growing as large floating clusters in ULA plates ( Fig. 2A; top) . In contrast, MCF7 and 357 T47D cells were more cohesive in 2D and formed tight spheres in ULA ( Fig. 2A; bottom) . 358 Despite having overall slower proliferation rates compared to the IDC cells, the ILC cell lines 359 had a remarkable ability to grow equally well in 2D and ULA plates, with BCK4 showing the 360 least robust ULA phenotype (Fig. 2B) . Importantly, this anchorage-independence was unique to 361 the ILC cells, as the IDC cell lines had much poorer growth in ULA versus 2D culture. 362 Interestingly, while MDA-MB-231 cells with no adherens junctions displayed a loose ULA 363 10 morphology more similar to ILC than IDC cells, they had the poorest ULA growth of all the IDC 364 cell lines. 365 366 Given the superior anchorage-independent growth of ILC cell lines compared to IDC, we also 367 assessed their ability to form mammospheres, which are similarly grown in ULA plates but with 368 a selective media that enriches for stem-like cells (24). Assessment of stemness in the ILC cell 369 lines was also of interest to us given the higher expression of stem cell markers such as 370 ALDH1A1 in ILC versus IDC tumors (34, 35) . Despite their robust growth in ULA conditions, 371 ILC cell lines formed poorly defined, loose mammospheres that were difficult to quantify, unlike 372 the tighter MCF7 and T47D spheres ( Supplementary Fig. S1A ). Flow cytometric analysis of 373 stem cell markers similarly did not identify a putative CD24 low /CD44 high or CD49f high /EPCAM low 374 stem cell population in the ILC cell lines ( Supplementary Fig. S1B-C Another form of anchorage-independence is the ability to grow in suspension in soft agar gels 381 (13). In general, ILC cell lines exhibited limited, dyscohesive growth in this semi-solid medium, 382 with BCK4 cells forming the smallest colonies ( Fig. 3A; top) . The ILC growth was similar to the 383 growth of MCF7 and T47D cells, the latter displaying a tighter morphology. As expected, MDA-384 MB-231 cells formed the most robust soft agar colonies, serving as a positive control. 385 Altogether, these assays indicate that ILC cells exhibit a unique anchorage-independence ability 386 in ULA conditions, a phenotype not replicated in soft agar or mammosphere culture. In tissues, ILC tumors grow as a single-file of cells within a dense layer of stroma rich in ECM 392 (1, 6) . This phenomenon can be visualized by staining human tumors with Masson's Trichrome, 393 which clearly demonstrates higher levels of collagen fibers in ILC compared to IDC 394 ( Supplementary Fig. S2 ). However, the 3D ECM growth of human ILC cell lines has not 395 previously been systematically analyzed. Therefore, we first embedded ILC cell lines in thick 396 Collagen I gels, where MDA-MB-134 and SUM44 cells exhibited the most robust growth, while 397 MDA-MB-330 cells displayed a looser morphology and BCK4 formed the smallest colonies 398 ( Fig. 3A) . Similar results were obtained when the cells were either embedded within or cultured 399 on top of Matrigel, displaying a "grape-like" morphology previously described for cells with 400 poor cell-cell adhesion (37). In contrast, MCF7 and T47D cells formed very tight colonies in all 401 ECM environments ( Fig. 3B) . Interestingly, MDA-MB-330 cells exhibited protrusive structures 402 11 in Matrigel culture ( Fig. 3A) , which are more characteristic of MDA-MB-231 cells with a 403 "stellate" morphology and known invasive potential ( Fig. 3B) (37) . 404 405 In addition to growing cells within 3D gels, we also assayed the adhesion of cells to ECM 406 proteins in 2D to gain a deeper understanding of their cell-matrix interactions (16). To this end, 407 we seeded ILC and IDC cell lines onto plates coated with Collagen I, Collagen IV, Fibronectin, 408 Laminin or Matrigel in serum free media. We also utilized uncoated plates for comparison and 409 bovine serum albumin (BSA) coated plates as negative control for background adhesion levels. 410 While a 2-hour incubation indicated a low level of overall binding in ILC cell lines, especially in 411 MDA-MB-134 and SUM44 cells (Supplementary Fig S3A) , a 16 hour-incubation resulted in 412 more efficient binding and varying cell morphologies on different matrices ( Fig. 4A and 413 Supplementary Fig. S3B ). The ECM protein most preferred for binding in general was 414 Collagen I ( Fig. 4B) , on which most cells displayed prominent adhesive protrusions ( Fig. 4A) , 415 followed by Collagen IV and Matrigel. Fig. S3C ) and matrix metalloproteinases (MMPs) 423 ( Supplementary Fig. S3D ), which are well known mediators of cell-matrix adhesion (16). 424 Combined, these data indicate that ILC cell lines have differing morphologies in 3D ECM gels 425 and divergent adhesive properties on matrix proteins. Next we assessed cell migration employing the commonly used wound-scratch assay, in which a 431 gap ("a wound") is introduced into the middle of a monolayer to induce directional movement of 432 cells from the wound edges (17, 25) . Using the IncuCyte live-cell imaging system and capturing 433 images of cells every 4 hours, we observed very limited basal migration in the ILC cell lines 434 ( Fig. 5A; left) . This was in stark contrast to the IDC cells ( Fig. 5A; right) , which completely 435 closed the wound in as early as 24 hours (MDA-MB-231). To exogenously induce cell 436 migration, we treated the cells with phorbol myristate acetate (PMA), which activates the PKC 437 pathway and downstream actin cytoskeleton reorganization (38). PMA treatment clearly 438 triggered migratory protrusions at the edges of the wound in MCF7 cells ( Fig. 5B ; right) and 439 substantially increased their migration rate ( Fig. 5C; right) . In contrast, however, despite 440 inducing protrusions in the otherwise-round ILC cell lines ( Fig. 5B; left) , PMA had limited 441 12 effect on their movement ( Fig. 5C; left) . While the strongest PMA effect was in BCK4, this cell 442 line still failed to close the wound after 72 hours. 443 444 As an alternative to the wound-scratch assay, we next utilized transwell Boyden chambers to 445 assess migration and invasion (17). As expected, the highly migratory MDA-MB-231 cells 446 exhibited substantial chemotaxis to FBS, while MCF7 and T47D cell were weakly migratory 447 ( Fig. 6A) . However, the ILC cell lines exhibited very limited migration to FBS in this assay. 448 Given the ECM-rich stroma of ILC tumors (1,6) (see Supplementary Fig. S2 ) , we also assayed 449 migration to substrate bound ECM in haptotaxis experiments (18), in which the undersides of the 450 inserts were coated with a thin layer of Collagen I. Interestingly, SUM44 and MDA-MB-330 451 cells displayed abundant haptotaxis to Collagen I over BSA in this assay ( Fig. 6B) , despite no 452 chemotaxis to FBS (see Fig. 6A ). This result was different from MCF7 and MDA-MB-231 cells, 453 which exhibited Collagen I haptotaxis ( Fig. 6B ) but also chemotaxis to FBS (see Fig. 6A ), 454 highlighting the unique requirement of matrix only by ILC cells for migration. However, this 455 finding did not extend to BCK4 or MDA-MB-134 cells, which did not migrate substantially in 456 either assay ( Fig. 6A-B) , with the phenotype of the latter being consistent with its weak ECM 457 adhesion (see Fig. 4 ). Supplementary Fig. 4A ). However, when assayed in either transwell Boyden chambers 469 ( Supplementary Fig. 4B -C) or wound-scratch assays ( Supplementary Fig. 4D) , none of the 470 tested alterations alone were sufficient to induce cell migration in MDA-MB-134 cells. Fig. S6A ). Differential expression analysis, based on a fold-change 504 cut-off value of 1.5 and false discovery rate (FDR) value of 0.05, identified 320 genes that were 505 expressed higher in ILC versus IDC cell lines and 387 that were expressed lower ( Fig. 7A We recently reported a transcriptomic comparison of ILC and IDC tumors from the TCGA (7) 519 and METABRIC (28) (Supplementary Fig. 6B) . Nevertheless, overlap of the differentially expressed 526 genes between ILC and IDC tumors (22) and those between ILC and IDC cell lines 527 (Supplementary Table 2) identified 14 upregulated and 17 downregulated genes, the latter 528 including CDH1 (Fig. 7D-E) . The query of these genes in the METABRIC dataset (28) revealed 529 that higher expression of PPFIBP2, as seen in cell lines and tumors from ILC versus IDC, was 530 significantly associated with worse disease-specific survival in ILC but not in IDC ( Fig. 7F;   531 top). Similarly, lower expression of PLOD2, as seen in ILC versus IDC tumors and cell lines, 532 exhibited a significant association with worse disease-specific survival in ILC but not in IDC 533 (Fig. 7F; bottom) . Collectively, these data highlight the sub-type specific, clinically relevant 534 gene expression programs that may account for the divergent biological phenotypes between ILC 535 and IDC cell lines and should be more deeply explored. 536   537   538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563 Overlaying the gene expression data from ILC and IDC cell lines with that from tumors, we 634 observed a completely separate clustering and very little overlap. This phenomenon has 635 previously been reported for ovarian cancer (45) and is not surprising given the much higher 636 complexity of in vivo settings compared to in vitro (15, 46) . Future gene expression profiling 637 studies of the cell lines cultured on ECM proteins analyzed in our study and/or in the presence of 638 stromal cell types such as fibroblasts should yield a better recapitulation of tumor transcriptional 639 programs. Nevertheless, our analysis identified a number of differentially regulated genes that 640 were common between the cell lines and tumors, some of which exhibited a significant 641 correlation with disease-free survival of ILC but not IDC tumors. This approach helped generate 642 a short list of clinically relevant genes that may be pertinent to the unique ILC biology. 643 644 PPFIBP2, also known as Liprin Beta 2, encodes a protein involved in the plasma membrane 645 recruitment of leukocyte common antigen-related receptor (LAR) protein-tyrosine phosphatases, 646 which regulate focal adhesions and mammary gland development (47). It is commonly fused to 647 oncogenes such as RET in thyroid cancer and the hypo-methylation of its enhancer is associated 648 with increased breast cancer risk (48). Since our data links PPFIB2 to poor survival specifically 649 in the ILC cohort, further functional interrogation of this understudied, candidate oncogenic 650 driver may implicate it as a novel therapeutic target in ILC. PLOD2 encodes an enzyme involved 651 in the hydroxylation of lysyl residues in collagen-like peptides and ECM remodeling (49). In 652 contrast to its promotion of metastasis in lung adenocarcinoma (50), the association of PLOD2 653 with better survival specifically in the ILC cohort suggests that decreased collagen crosslinking 654 may create a microenvironment more permissive to growth and dissemination in ILC, 655 underlining the importance of studying amoeboid migration and invasion. 
